FIGURE 2.
Impact on survival of ASCT and high-risk cytogenetic abnormalities [del (17p), t(4;14) and 1q21 gain]. PFS = progression-free survival, ASCT = autologous stem cell transplantation.
Impact on survival of ASCT and high-risk cytogenetic abnormalities [del (17p), t(4;14) and 1q21 gain]. PFS = progression-free survival, ASCT = autologous stem cell transplantation.